Corrigendum to "Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol" [Toxicology and Applied Pharmacology, 378 (2019) 114619]
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu tisková chyba
PubMed
31398422
DOI
10.1016/j.taap.2019.114701
PII: S0041-008X(19)30309-6
Knihovny.cz E-zdroje
- Publikační typ
- tisková chyba MeSH
Department of Oncology Taipei Veterans General Hospital Taipei Taiwan
Department of Pharmacy Taipei Veterans General Hospital Taipei Taiwan
Department of Surgery Taipei Veterans General Hospital Taipei Taiwan
Department of Toxicogenomics National Institute of Public Health Prague Czech Republic
National Research Institute of Chinese Medicine Taipei Taiwan
Citace poskytuje Crossref.org